Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
4.390
+0.310 (7.60%)
At close: May 27, 2025, 4:00 PM
4.430
+0.040 (0.91%)
After-hours: May 27, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $1.79 billion as of May 27, 2025. Its market cap has decreased by -12.62% in one year.
Market Cap
1.79B
Enterprise Value
1.38B
1-Year Change
-12.62%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $1.79B, a decrease of -64.80%. That is a compound annual growth rate of -22.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 1.66B | -37.73% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.99B |
| Johnson & Johnson | 367.96B |
| AbbVie | 327.54B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 263.43B |
| Abbott Laboratories | 231.45B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |